# LevelsRx reviews (2026): GLP-1 telehealth sellers | This GLP

Two starting prices on a seller whose cost rises with the dose, and no ceiling published.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/levelsrx
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Two floors, no ceiling

# LevelsRx review

Two starting prices on a seller whose cost rises with the dose, and no ceiling published.

## The verdict

LevelsRx publishes starting prices of $150 a month for semaglutide and $240 for tirzepatide. An oral liposomal liquid is offered alongside the injection.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

Dose pricing

Rises with dose

From

From $150/mo

Prescription

Required

Compounded

Yes — not FDA-approved

LevelsRx sells both molecules. Semaglutide comes as an injection or an oral liposomal liquid. Both figures are starting prices.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription precedes shipping. The pages name products. No clinician is described and no intake is documented.
    
    Two formats on one line is the structure here. Which one a buyer takes is not priced separately on the pages read.
    
2.  ## What happens when the dose goes up?
    
    The cost rises with the dose. What it rises to is not published. Direction without a destination is half an answer.
    
3.  ## What the price includes
    
    $150 and $240 are floors. Six months at them is $900 and $1,440 at best. A rising price makes both totals a minimum rather than an estimate. Ask what the figure is at a therapeutic dose.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: An oral and an injectable option
-   Strength: Both molecules carry a figure
-   Strength: The rising price is on the record
-   Limitation: Both figures are starting prices
-   Limitation: The upper rungs are not published
-   Limitation: No milligram dose stated
-   Limitation: No state coverage list is recorded

## What the evidence says about this kind of treatment

The assessment above is about LevelsRx. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who wants the oral option and will ask what the ladder costs.

Wrong for

A reader who needs a ceiling, since neither figure has one.

## The evidence behind what LevelsRx prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How LevelsRx compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| LevelUp Rx | Readers who want the billed total before committing to a term |  |
| Longevixx | Readers wanting a flat rate in any state |  |
| LVNG RX | Readers who want a bundle and accept the figure is confirmed later |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Rex MD](https://thisglp.com/reviews/rex-md) [Rivas Medical Weight Loss](https://thisglp.com/reviews/rivas-medical) [Rivo Health](https://thisglp.com/reviews/rivo-health) [Rixa Health](https://thisglp.com/reviews/rixa-health) [RNK Health](https://thisglp.com/reviews/myrnk) [Ro](https://thisglp.com/reviews/ro)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Does the price rise with the dose?

Yes, and what it rises to is not published. Ask before ordering.

What is the oral option?

A liposomal liquid semaglutide, offered alongside the injection.

Is $150 a rate?

No. It is a starting price on a line that scales with dose.

Is LevelsRx expensive compared with other GLP-1 telehealth sellers?

LevelsRx publishes a starting figure of $150/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts LevelsRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
